Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria

OBJECTIVES: The coagulation-inflammation cycle has been implicated as a critical component in malaria pathogenesis. Defibrotide (DF), a mixture of DNA aptamers, displays anticoagulant, anti-inflammatory, and endothelial cell (EC)-protective activities and has been successfully used to treat comatose...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Francischetti, Ivo M. B., Oliveira, Carlo J., Ostera, Graciela R., Yager, Stephanie B., Debierre-Grockiego, Françoise, Carregaro, Vanessa, Jaramillo-Gutierrez, Giovanna, Hume, Jen C., Jiang, Lubin, Moretz, Samuel E., Lin, Christina K., Ribeiro, José M.C., Long, Carole A., Vickers, Brandy K., Schwarz, Ralph T., Seydel, Karl B., Iacobelli, Massimo, Ackerman, Hans C., Srinivasan, Prakash, Gomes, Regis B., Wang, Xunde, Monteiro, Robson Q., Kotsyfakis, Michail, Sá-Nunes, Anderson, Waisberg, Michael
פורמט: Artigo
שפה:Inglês
יצא לאור: 2011
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3288196/
https://ncbi.nlm.nih.gov/pubmed/22116094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.111.240291
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים